Literature DB >> 15663962

Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis.

Johann Sellner1, Florian Dvorak, Yilin Zhou, Jürgen Haas, Roland Kehm, Brigitte Wildemann, Uta Meyding-Lamadè.   

Abstract

Mortality and morbidity rates remain high among patients with herpes simplex virus encephalitis (HSVE). Chemokine-mediated recruitment and activation of leukocytes to focal areas of viral CNS infection are crucial steps in antiviral response and clearance. However, the inflammatory reaction and cellular antiviral response may enhance collateral damage to neurons and account for chronic progressive brain damage. We identified a specific mRNA expression of the interferon-gamma-inducible chemokines (CXCL9, CXCL10 and CXCL11), and RANTES (CCL5) in the acute course and long-term of experimental HSVE. This pattern was substantially altered by anti-viral and anti-inflammatory treatment. Our findings indicate a pivotal role of these chemokines in the immunopathogenesis of HSVE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15663962     DOI: 10.1016/j.neulet.2004.10.054

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

1.  Antibodies to N-methyl-D-aspartate and other synaptic receptors in choreoathetosis and relapsing symptoms post-herpes virus encephalitis.

Authors:  Maarten J Titulaer; Frank Leypoldt; Josep Dalmau
Journal:  Mov Disord       Date:  2013-11-04       Impact factor: 10.338

2.  TLR signaling controls lethal encephalitis in WNV-infected brain.

Authors:  Amir H Sabouri; Maria Cecilia Garibaldi Marcondes; Claudia Flynn; Michael Berger; Nengming Xiao; Howard S Fox; Nora E Sarvetnick
Journal:  Brain Res       Date:  2014-06-11       Impact factor: 3.252

3.  Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.

Authors:  Megan Steain; Kavitha Gowrishankar; Michael Rodriguez; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

4.  Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation.

Authors:  Jason B Weinberg; Daniel R Jensen; Lisa E Gralinski; Amy R Lake; Gregory S Stempfle; Katherine R Spindler
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

5.  HSV encephalitis-induced anti-NMDAR encephalitis in a 67-year-old woman: report of a case and review of the literature.

Authors:  Nicholas A Morris; Tamara B Kaplan; Jenny Linnoila; Tracey Cho
Journal:  J Neurovirol       Date:  2015-07-03       Impact factor: 2.643

6.  Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis.

Authors:  Anibal G Armien; Shuxian Hu; Morgan R Little; Nicholas Robinson; James R Lokensgard; Walter C Low; Maxim C-J Cheeran
Journal:  Brain Pathol       Date:  2009-11-05       Impact factor: 6.508

Review 7.  Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis.

Authors:  Hui Liu; Ke Qiu; Qiang He; Qiang Lei; Wei Lu
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-19       Impact factor: 4.147

8.  Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis.

Authors:  Márcia Carvalho Vilela; Graciela Kunrath Lima; David Henrique Rodrigues; Norinne Lacerda-Queiroz; Vinicius Sousa Pietra Pedroso; Aline Silva de Miranda; Milene Alvarenga Rachid; Erna Geessien Kroon; Marco Antônio Campos; Mauro Martins Teixeira; Antonio Lucio Teixeira
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-19       Impact factor: 4.147

9.  N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis.

Authors:  Harald Prüss; Carsten Finke; Markus Höltje; Joerg Hofmann; Christine Klingbeil; Christian Probst; Kathrin Borowski; Gudrun Ahnert-Hilger; Lutz Harms; Jan M Schwab; Christoph J Ploner; Lars Komorowski; Winfried Stoecker; Josep Dalmau; Klaus-Peter Wandinger
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

10.  Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933].

Authors:  Francisco Martinez-Torres; Sanjay Menon; Maria Pritsch; Norbert Victor; Ekkehart Jenetzky; Katrin Jensen; Eva Schielke; Erich Schmutzhard; Jan de Gans; Chin-Hee Chung; Steffen Luntz; Werner Hacke; Uta Meyding-Lamadé
Journal:  BMC Neurol       Date:  2008-10-29       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.